Abstracts Archive - Page 2445 of 2607 - ACR Meeting Abstracts

Abstract Number: 2398 • 2012 ACR/ARHP Annual Meeting
Pauci-Immune Glomerulonephritis in the Elderly: Disease Severity and Outcomes
Rebecca L. Manno¹, Duvuru Geetha², Stuart M. Levine³, Philip Seo⁴ and Allan C. Gelber⁵, ¹Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ²Nephrology, Johns Hopkins University, Baltimore, MD, ³Medicine/Rheumatology, Johns Hopkins University, Baltimore, MD, ⁴Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, ⁵Medicine/ Rheumatology, Johns Hopkins University, Baltimore, MD
Background/Purpose: Incident cases of pauci-immune glomerulonephritis affect adults at the older end of the age spectrum though relevant published data are limited. We sought to…
Abstract Number: 2399 • 2012 ACR/ARHP Annual Meeting
Exercise On Prescription: Barriers to Participation in Community Based Exercise Programmes
Dr Nicola E. Walsh¹ and Professor Mike Hurley², ¹Allied Health Professions, University of the West of England, Bristol, United Kingdom, ²School of Rehabilitation Sciences, St George's University of London and Kingston University, London, United Kingdom
Background/Purpose: Osteoarthritis (OA) is highly prevalent, disabling and incurs considerable healthcare costs. Symptoms of pain and functional impairment can be ameliorated through participation in regular…
Abstract Number: 2400 • 2012 ACR/ARHP Annual Meeting
Hospital for Special Surgery Osteoarthritis Wellness Initiative: the Impact of a Hospital-Based Exercise Program On Osteoarthritis
Sandra Goldsmith¹, Dana Friedman¹, Linda Roberts¹, Dana Sperber¹ and Laura Robbins², ¹Public and Patient Education, Hospital for Special Surgery, New York, NY, ²Education & Academic Affairs, Hospital for Special Surgery, New York, NY
Background/Purpose: The Centers for Disease Control and Prevention (CDC) reports that about 27 million adults were affected by osteoarthritis (OA) in 2005. OA is characterized…
Abstract Number: 2401 • 2012 ACR/ARHP Annual Meeting
An International Framework for Chronic Condition Self Management Support: Results from an International Electronic Consultation Process.
Teresa J. Brady¹, Sue Mills², Peter Sargious³ and Shabnam Ziabakhsh⁴, ¹Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ³Chronic Disease Management Portfolio, Alberta Health Services, Calgary, AB, Canada, ⁴Amabulatory Programs, BC Women's Hospital & Health Centre, Vancouver, BC, Canada
Background/Purpose: Self-management support (SMS) –a grouping of policies, programs, services, and structures that extend across health care, social sectors and communities to support and improve…
Abstract Number: 2402 • 2012 ACR/ARHP Annual Meeting
Clinical Utility of the Hospital Anxiety and Depression Scale for an Outpatient Fibromyalgia Education Program
Diane Tin¹, Lorna J. Bain¹, J. Carter Thorne², Seungree Nam³ and Liane Ginsburg⁴, ¹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Faculty of Heatlh, York University, Toronto, ON, Canada, ⁴School of Health Policy and Management, York University, Toronto, ON, Canada
Background/Purpose: The Arthritis Program (TAP) at Southlake Regional Health Centre has offered an inter-professional, patient centered Fibromyalgia (FM) education program for nearly two decades. This…
Abstract Number: 2403 • 2012 ACR/ARHP Annual Meeting
The Effect of a Rheumatoid Arthritis Peer Support Program On Clinical Outcomes
Rebecca Thrower¹, Christine K. Iannaccone², Hsun Tsao³, Michael Weinblatt⁴, Jing Cui² and Nancy A. Shadick⁵, ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁴Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ⁵Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: To evaluate the effect of a rheumatoid arthritis (RA) peer support program on fatigue, functional status (pain, SF-12 PCS), self-efficacy, emotional health (SF-12 MCS)…
Abstract Number: 2404 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus and/or Antiphospholipid Antibody Positive Patients: Two-Year Preliminary Analysis of Diet and Exercise Habits
Virginia Haiduc¹, Monica C. Richey¹, Sotiria Everett², Aeshita Dwivedi¹, Lisa Konstantellis¹, Hassan Ghomrawi³ and Doruk Erkan⁴, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Hospital for Special Surgery, New York, NY, ³Healthcare Research and Policy, Weill Cornell Medical College, New York, NY, ⁴Rheumatology Dept, Hospital for Special Surgery, New York, NY
Background/Purpose: SLE patients have high rate of cardiovascular events due to increased prevalence of traditional cardiovascular disease (CVD)- and other lupus-related thrombosis risk factors. In…
Abstract Number: 2365 • 2012 ACR/ARHP Annual Meeting
Asymptomatic Myocardial Ischemic Disease in Takayasu’s Arteritis
Chloe Comarmond¹, Odile Dessault², jean-Yves Devaux², Nathalie Costedoat-Chalumeau³, Mathieu Resche Rigon⁴, Richard Isnard⁵, Fabien Koskas⁶, Patrice Cacoub Sr.⁷ and David Saadoun⁸, ¹Internal Medicine, Hôpital Pitié Salpétrière, Paris, France, ²Department of Nuclear Medicine, Groupe Hospitalier Saint-Antoine, Paris, France, ³Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, ⁴Department of Internal Medicine and Laboratory I3 “Immunology, Immunopathology, Immunotherapy”, UMR CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-Salpetrière, Université Pierre et Marie Curie, Paris 6, Paris, France, Paris, France, ⁵Cardiology, CHU Pitié-Salpêtrière, 47-83 Boulevard de l'hôpital, 75651 Paris Cedex 13, Paris, France, Paris, France, ⁶Department of Internal Medicine and 2Laboratory I3 « Immunology, Immunopathology, Immunotherapy », UMR CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-Salpetrière, Université Pierre et Marie Curie, Paris 6, Paris, France, Paris, France, ⁷Department of Internal Medicine 2., CHU Pitié-Salpêtrière, Paris, France, ⁸DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France
Background/Purpose: Cardiac involvement in Takayasu's arteritis (TA) is a leading cause of death. Previous studies reported a high incidence of myocardial involvement using exercise thallium-201…
Abstract Number: 2366 • 2012 ACR/ARHP Annual Meeting
Aortic and Coronary Calcifications in Takayasu Arteritis
Emire Seyahi¹, Ayca Ucgul², Serdal Ugurlu¹, Canan Akman³, Deniz Cebi Olgun³, Sebahattin Yurdakul¹ and Hasan Yazici¹, ¹Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, ²Internal Medicine, University of Istanbul, Cerrahpasa Medical Faculty, Istanbul, Turkey, ³Radiology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
Aortic and coronary calcifications in Takayasu arteritisBackground/Purpose: We had previously shown, similar to patients with systemic lupus erythematosus (SLE), patients with Takayasu arteritis (TAK) had…
Abstract Number: 2367 • 2012 ACR/ARHP Annual Meeting
Presence of Fibromyalgia and Fatigue Is Not Increased in Patients with Takayasu’s Arteritis
Fatma Alibaz-Oner¹, Meryem Can¹, Birkan Ilhan², Ozge Polat² and Haner Direskeneli¹, ¹Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ²Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: Takayasu’s arteritis (TAK) is a large-vessel vasculitis of the aorta and its major branches. To our knowledge, no data is reported about the frequency…
Abstract Number: 2368 • 2012 ACR/ARHP Annual Meeting
Tocilizumab in Refractory Takayasu’s Arteritis: 7 Patients Followed At a Single Italian Centre
Enrico Tombetti¹, Elena Baldissera², Stefano Franchini¹, Patrizia Aiello³, Francesca Motta¹, Barbara Gulgielmi¹ and Maria Grazia Sabbadini¹, ¹Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, ²Vita-Salute San Raffaele University, Milano, Italy, ³Internal Medicine and Clinical Immunology, Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy
Background/Purpose: Takayasu arteritis (TA) is a rare chronic-relapsing vasculitis involving primarily the aorta and its major branches.TA is associated with considerable morbidity and mortality. Therapy…
Abstract Number: 2369 • 2012 ACR/ARHP Annual Meeting
Aspects of Innate Immunity in Behçet´s Disease: A Model of Autoinflammatory Disease?
Sandro F. Perazzio¹, Paulo Vitor Soeiro Pereira², Alexandre Wagner S. de Souza³, Antonio Condino-Neto² and Luis Eduardo C. Andrade⁴, ¹Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, ²Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, ³Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, ⁴Rheumatology Division, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil
Background/Purpose: Behçet's disease (BD) is a systemic vasculitis of unknown etiopathogenesis. Increased neutrophil activation has been previously shown in BD patients and it is unclear…
Abstract Number: 2370 • 2012 ACR/ARHP Annual Meeting
A Genome-Wide DNA Methylation Study Identifies Significant Epigenetic Changes Across the Genome and in Multiple HLA Loci in Behcet’s Disease
Haner Direskeneli¹, Patrick S. Coit², Filiz Ture-Ozdemir¹, Fatma Alibaz-Oner¹, Guher Saruhan-Direskeneli³, Matlock A. Jeffries⁴ and Amr H. Sawalha², ¹Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ²Division of Rheumatology, University of Michigan, Ann Arbor, MI, ³Department of Physiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ⁴Medicine, University of Oklahoma and Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Behcet’s disease (BD) is a systemic vasculitis of poorly understood etiology. Herein, we study the DNA methylome in BD for the first time and…
Abstract Number: 2371 • 2012 ACR/ARHP Annual Meeting
The Unmet Need in Behcet’s Disease: Most Patients Are Not in Complete Remission in the Long-Term Follow-up
Fatma Alibaz-Oner¹, Gonca Mumcu², Gülsen Ozen³, Zeynep Kubilay⁴, Meryem Can¹, Sibel Yýlmaz Oner¹, Tülin Ergun⁵ and Haner Direskeneli¹, ¹Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ²Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, ³Rheumatology, Marmara University School of Medicine., Istanbul, Turkey, ⁴Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey, ⁵Dermatology, Marmara University School of Medicine, Istanbul, Turkey
Background/Purpose: The nature of Behcet’s disease (BD) as a multi-systemic disorder with a remitting-relapsing course is unsufficiently explored. As complete remission should be aimed in…
Abstract Number: 2372 • 2012 ACR/ARHP Annual Meeting
Efficacy of Quantitative Analysis of Brainstem Atrophy On Magnetic Resonance Imaging for Diagnosis of Chronic Progressive Neuro-Behçet’s Disease
Hirotoshi Kikuchi¹, Maki Takayama², Yoshitaka Kimura², Kurumi Asako², Hajime Kono², Yasuo Ono¹ and Shunsei Hirohata³, ¹Department of Microbiology and Immunology, Teikyo University Shool of Medicine, Tokyo, Japan, ²Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, ³Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan
Background/Purpose : CNS involvement in Behçet's disease, usually called neuro-Behçet's disease (NB), can be classified into acute NB (ANB) and chronic progressive NB (CPNB) based…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].